BioCentury
ARTICLE | Company News

AlCana, Alnylam, Tekmira drug delivery news

July 23, 2012 7:00 AM UTC

The Massachusetts Superior Court denied a request by Alnylam and AlCana for leave to file motions for summary judgment in a suit brought by Tekmira alleging that Alnylam and AlCana misused and exploited trade secrets related to Tekmira's lipid nanoparticle short interfering RNA delivery technology. The court set a trial date of Oct. 30. Tekmira filed the suit against Alnylam last year and subsequently added AlCana as a defendant and the additional claims of breach of agreement, breach of implied covenant of good faith and fair dealing, civil conspiracy and tortuous interference with contractual relationships (see BioCentury, March 21, 2011 & June 13, 2011). ...